2011Linchuang gandanbing zazhiRequires access

Clinical study on adefovir dipivoxil treatment on patients with chronic hepatitis B:65 case report

Zhai Peiren

Open publisher page 0 citations

Abstract

Objective To evaluate the efficacy of adefovir dipivoxil treatment on patients with chronic hepatitis B.Methods Adefovir dipivoxil and lamivudine were given to 39 patients with HBeAg-positive,and adefovir dipivoxil was given to 12 with HBeAg-positive and to 14 with HBeAg-negative hepatitis B,respectively for 24 weeks.Results Serum HBV DNA undetectable rates at 3 mon,6 mon,12 mon and 24 mon both in HBeAg-positive patients with adefovir dipivoxil and lamivudine or in HBeAg-negative patients with adefovir dipivoxil alone were higher than in HBeAg-positive patients with adefovir dipivoxil alone;the normalization of ALT in the three groups were not significantly different.Conclusion We recommend combination of adefovir dipivoxil and lamivudine therapy for patients HBeAg-positive hepatitis B.

About this research paper

What this paper is about

Objective To evaluate the efficacy of adefovir dipivoxil treatment on patients with chronic hepatitis B.Methods Adefovir dipivoxil and lamivudine were given to 39 patients with HBeAg-positive,and adefovir dipivoxil was given to 12 with HBeAg-positive and to 14 with HBeAg-negative hepatitis B,respectively for 24 weeks.Results Serum HBV DNA undetectable rates at 3 mon,6 mon,12 mon and 24 mon both in HBeAg-positive patients with adefovir dipivoxil and lamivudine or in HBeAg-negative patients with adefovir dipivoxil alone were higher than in HBeAg-positive patients with adefovir dipivoxil alone;the normalization of ALT in the three groups were not significantly different.Conclusion We recommend combination of adefovir dipivoxil and lamivudine therapy for patients HBeAg-positive hepatitis B.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To evaluate the efficacy of adefovir dipivoxil treatment on patients with chronic hepatitis B.Methods Adefovir dipivoxil and lamivudine were given to 39 patients with HBeAg-positive,and adefovir dipivoxil was given to 12 with HBeAg-positive and to 14 with HBeAg-negative hepatitis B,respectively for 24 weeks.Results Serum HBV DNA undetectable rates at 3 mon,6 mon,12 mon and 24 mon both in HBeAg-positive patients with adefovir dipivoxil and lamivudine or in HBeAg-negative patients with adefovir dipivoxil alone were higher than in HBeAg-positive patients with adefovir dipivoxil alone;the normalization of ALT in the three groups were not significantly different.Conclusion We recommend combination of adefovir dipivoxil and lamivudine therapy for patients HBeAg-positive hepatitis B.

Key concepts: Adefovir, Lamivudine, Medicine, Chronic hepatitis, HBeAg, Gastroenterology, Internal medicine, Hepatitis B

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical study on adefovir dipivoxil treatment on patients with chronic hepatitis B:65 case report — Research Paper | ScholarLens